This series of Annals of Translational Medicine presents a collection of review articles on the treatment of gastric and gastroesophageal cancer in 2020. The treatment of this cancer has been evolving overtime in both the locally advanced and the metastatic setting. Treatment ranges from Endoscopic resection in early stage disease and perioperative chemotherapy in locally advanced disease to combination of chemotherapy and targeted therapy in the metastatic setting.
Editorial on Gastroesophageal Cancer 2020
Editorial for the series on gastric and gastroesophageal cancer treatment in 2020
Review Articles on Gastroesophageal Cancer 2020
Palliative care for patients with esophageal cancer: a narrative review
Targeted therapies for gastroesophageal cancers
Esophageal cancer in Aleppo, Syria 2010–2020: a rare cancer in a war zone
Narrative review of the role of gastroenterologist in the diagnosis, treatment and palliation in gastric and gastroesophageal cancer
A narrative review of Barrett’s esophagus in 2020, molecular and clinical update
Locoregional gastric cancer: a narrative review of multidisciplinary management
Treatment for metastatic adenocarcinoma of the stomach and gastroesophageal junction: 2020
Does tumor profile in gastric and gastroesophageal (GE) junction cancer justify off-label use of targeted therapy?—a narrative review
Disclosure:
The series “Gastroesophageal Cancer 2020” was commissioned by the editorial office, Annals of Translational Medicine without any sponsorship or funding. Khaldoun Almhanna served as the unpaid Guest Editor for the series.